// App-Quantinova.ai

7 : Dupilumab Improves EASI Regional Scores Across All Anatomical Regions in Children Aged â?¥6â??<12 Years With Severe Atopic Dermatitis

Researchers

Presenter

  • Brad Shumel

Principal Investigators

  • Danielle Marcoux

  • Andreas Wollenberg

  • Randy Prescilla

  • Zhen Chen

  • Ana Rossi

Medical Centers

  • University of Montreal and Centre Hospitalier Universitaire Sainte-Justine Montreal Montreal Quebec Canada

  • Ludwig-Maximilians-Universitaet (LMU), Munich, Germany

  • Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States.

  • University of Sheffield, Sheffield, United Kingdom

  • None Cambridge Massachusetts United States

Locations

  • Canada

  • Germany

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Dermatology

Disease

  • Atopic Dermatitis

Biomarkers

  • N/A

Drug/Treatment

  • Dupilumab

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

Phase

  • III

Study Id's

  • NCT03345914

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved